Sign In
Buy NDAQ
$77.65
-3.96 (-4.85%)
At Close: Jun 25, 2026
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Monday, 08'th Jul 2024
BEDFORD, Mass., July 08, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL) (“Ocular”, the “Company” ), a biopharmaceutical company committed to enhancing people's vision and qual
Nasdaq Index, Dow Jones, S&P 500 News: Morphic Holding Shares Surge Over 75%; Alibaba Group Stumbles
08:57am, Monday, 08'th Jul 2024
Nasdaq flat, but Alibaba shares dip 1.17% pre-market as AI progress showcased at Shanghai conference.
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
04:31pm, Friday, 05'th Jul 2024
PALO ALTO, Calif., July 05, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage biopharmaceutical company focused on genetic disea
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Friday, 05'th Jul 2024
BRISBANE, Calif., July 05, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on July 1, 2024, the Compensation Committee of Vera's Board of Directors granted inducem
Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04:01pm, Friday, 05'th Jul 2024
THOUSAND OAKS, Calif.--(BUSINESS WIRE)---- $ATRA #CART--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell pl
Nasdaq Surges Over 100 Points; Sharps Technology Shares Spike Higher
12:11pm, Friday, 05'th Jul 2024
U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Friday.
AGBA Group, one of Nasdaq's top 10 best-performing stocks for 2024, further cements strategic partnership with Yorkville
09:00am, Friday, 05'th Jul 2024
LOS ANGELES, July 05, 2024 (GLOBE NEWSWIRE) -- NASDAQ-listed, AGBA Group Holding Limited (“AGBA” or the “Company” or the “Group”), entered into an Amended and Restated Standby Equity Purch
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
08:00am, Friday, 05'th Jul 2024
DALLAS, July 05, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for
Bionano Announces up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
08:00am, Friday, 05'th Jul 2024
$10 million upfront with up to an additional $20 million upon the exercise in full of clinical milestone-linked Series Warrants $10 million upfront with up to an additional $20 million upon the exerci
VS Media Holdings Limited Regains Compliance with Nasdaq Minimum Closing Bid Price Requirement
08:00am, Friday, 05'th Jul 2024
HONG KONG, July 05, 2024 (GLOBE NEWSWIRE) -- VS Media Holdings Limited (NASDAQ: VSME , the "Company"), a leader in managing a global network of digital creators, today announced the receipt of forma
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07:30am, Friday, 05'th Jul 2024
SAN DIEGO, July 05, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicine
Nasdaq Underdogs: 3 Beaten-Down Stocks Primed for a July Comeback
06:00am, Friday, 05'th Jul 2024
As hot as the S&P 500 has been, the Nasdaq 100 is performing even better. The tech-heavy index is up 19% year-to-date (YTD) and 83% higher since the beginning of 2023.
UK-based IT firm Noventiq scraps SPAC deal to list on Nasdaq
09:33am, Thursday, 04'th Jul 2024
July 4 (Reuters) - London-headquartered information technology firm Noventiq and special purpose acquisition company Corner Growth Acquisition have mutually agreed to terminate their blank-check deal,
History Says the Nasdaq Will Soar: 2 Remarkable Growth Stocks to Buy Now for the Bull Market
05:12am, Thursday, 04'th Jul 2024
The Nasdaq Composite has advanced 76% so far during this bull market, but the index has returned an average of 215% during bull markets since 1990. Alphabet reported accelerating revenue and earnings
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:15pm, Wednesday, 03'rd Jul 2024
MIAMI--(BUSINESS WIRE)---- $SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced the grant of inducement awards of options to purchase a collective total of
